INC Research Selects Medidata Rave Electronic Data Capture, Management & Reporting Solution
FOR IMMEDIATE RELEASE
INC Research Selects Medidata Rave Electronic Data Capture,
Management & Reporting Solution
Leading Contract Research Organization Leverages Medidata’s
EDC Platform to Drive Corporate Growth Strategy
NEW YORK, NY – December 13, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced its strategic partnership with INC Research, a therapeutically focused contract research organization with a trusted process for delivering results. Through Medidata’s ASPire to Win™ Program, INC Research will implement Medidata Rave® to support its customers across the U.S., Europe, Asia, South America and other locations worldwide.
INC Research, which began building EDC expertise among its staff as early as 2001, has been a leader in the successful completion of studies using EDC technologies. INC Research interviewed 16 different industry vendors, and quickly narrowed the field to select Medidata Rave. Rave was chosen for its ease of deployment, user friendliness, intuitive interface, unique reporting capabilities and the level of supplemental support available from Medidata. INC Research was also impressed with Rave’s ability to present clinical data in any language in real-time around the world, a critical component of INC Research’s Asian strategy as well as growth in other areas.
INC Research’s ability to maintain a highly customer-centric focus has been a key driver of corporate growth and serves as the cornerstone of the company’s Trusted Process™ methodology for conducting clinical trials and non-trial related data projects.
“We selected Medidata because they are an industry leader in the EDC space, and because their solution meshes well with our Trusted Process,” said Alistair Macdonald, vice president of data services for INC Research. “For instance, our QuickStart™ portion of the Process is now enhanced by Rave because customers will have a truly global EDC platform that is easier to set up. Data can be collected faster with Rave, which enhances the Program Acceleration portion of the Process. Rave will also allow us to close the database faster. This makes the final portion of our Process, called QualityFinish, even more notable as database closeout may occur many weeks earlier, giving our customers the data they need sooner.”
Medidata Rave will also allow the entire research team—sponsors and INC Research employees—to have access to data in real-time.
Medidata’s ASPire to Win Program is a non-exclusive application service provider (ASP) partnership and business model. The program will allow INC Research to meet sponsor demand for Medidata Rave and offer the platform in-house. As a result, INC Research will be able to create new services revenue around the implementation of this industry-leading technology.
“As one of the earliest adopters of EDC technology and a company that has played a key role in enabling its customers to move to electronic solutions, INC Research is a natural fit for us,” said Tarek Sherif, CEO of Medidata Solutions. “Medidata Rave’s ability to scale to support any size trial or sponsor will allow INC Research to further expand its growing number of customers. We look forward to working together to extend the reach of EDC.”
About INC Research®
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase 1–Phase 4 programs in therapeutic areas of specialty, and in innovative pediatric trials. Our “Trusted Process™” methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, and in 21 locations in 30 countries worldwide. For more information, visit www.incresearch.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Working with companies and institutions both large and small, Medidata Solutions helps accelerate the process of safely bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com